Early stage company Cleveland HeartLab, a specialty clinical laboratory that is developing propriety diagnostic tests for measuring a patient's risk for heart disease, said it has completed a $3 million fundraising round and has selected its top officers.
Cleveland HeartLab secures $3 million in financing, selects top officers
Letter
to the
Editor
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Recommended for You
Sponsored Content